Changing radiation doses during treatment for adults with glioma
Original title: Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage study in people, so it is still being tested.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether scans taken during radiation can guide changes to the dose.
Who this trial is for. This trial is for adults with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, a common brain tumor in adults. Everyone gets standard radiation, with scans done twice during treatment so the dose to certain areas can be changed with help from a computer tool.
Where it stands. The trial has not reported results. It is testing whether a computer workflow can guide dose changes during radiation, and that answer is not in yet.
What this means, and what it doesn't
What it could mean: The study plans to include 60 patients at Tata Memorial Centre. If you have a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary and are facing radiation, you can ask your care team whether a study like this fits you. They will know your case.
What it doesn't mean: This does not mean the approach works. A trial is a test, not a proven treatment. Joining one is not a promise that it will help you, and it is not a cure.
Source: ClinicalTrials.gov, August 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.